Abiopharma

New Form 4 - Royalty Pharma plc Filed: 2025-08-08 AccNo: 0001802768-25-000105 Size: 19 KB

New Form 3 - CATALYST PHARMACEUTICALS, INC. Filed: 2025-08-08 AccNo: 0001161697-25-000221 Size: 5 KB

Simulations Plus, Inc. (SLP) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

CV Sciences, Inc. To Announce Second Quarter 2025 Results On August 13, 2025

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

New Form 8-K - Earth Science Tech, Inc. Filed: 2025-08-08 AccNo: 0001641172-25-022803 Size: 244 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 4 - Royalty Pharma plc Filed: 2025-08-08 AccNo: 0001802768-25-000104 Size: 14 KB

New Form 8-K - Quantum-Si Inc Filed: 2025-08-08 AccNo: 0001816431-25-000056 Size: 3 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 4 - Royalty Pharma plc Filed: 2025-08-08 AccNo: 0001802768-25-000103 Size: 18 KB

New Form 4 - OPKO HEALTH, INC. Filed: 2025-08-08 AccNo: 0000950170-25-105971 Size: 15 KB

New Form 4 - Royalty Pharma plc Filed: 2025-08-08 AccNo: 0001802768-25-000102 Size: 5 KB

New Form 8-K - WINDTREE THERAPEUTICS INC /DE/ Filed: 2025-08-08 AccNo: 0001437749-25-025762 Size: 152 KB Item 8.01: Other Events

New Form 4 - Elite Health Systems Inc. Filed: 2025-08-08 AccNo: 0001437749-25-025760 Size: 5 KB

New Form 4 - Royalty Pharma plc Filed: 2025-08-08 AccNo: 0001802768-25-000101 Size: 9 KB

New Form 4 - Elite Health Systems Inc. Filed: 2025-08-08 AccNo: 0001437749-25-025759 Size: 5 KB